GSK plc
GSK
#219
Rank
HK$807.74 B
Marketcap
HK$402.53
Share price
-0.29%
Change (1 day)
33.52%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): HK$30.37

According to GSK plc's latest financial reports the company's current EPS (TTM) is HK$30.45. In 2025 the company made an earnings per share (EPS) of HK$29.52 an increase over its 2024 EPS that were of HK$12.49.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$30.372.89%
2025HK$29.52136.36%
2024HK$12.49-47.35%
2023HK$23.72-64.2%
2022HK$66.26182.29%
2021HK$23.47-18.07%
2020HK$28.6522.34%
2019HK$23.4223.9%
2018HK$18.90140.61%
2017HK$7.8664.45%
2016HK$4.78-90.61%
2015HK$50.86178.12%
2014HK$18.29-48.11%
2013HK$35.2422.68%
2012HK$28.72-11.31%
2011HK$32.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.00 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.05-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$27.87-8.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.45 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$10.73-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
-HK$2.51-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA